---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-040985"
form_type: "8-K"
ticker: "PETV"
cik: "0001512922"
company_name: "PetVivo Holdings, Inc."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:30:06.257131+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PetVivo Q2 FY2024 net loss widens to $3.66M; revenue down to $207K

## Summary
- Revenue $207,366 vs $223,280 YoY, driven by lower clinic sales ($63,760 vs $105,016).
- Net loss $3.66M ($0.28 EPS) vs $2.11M ($0.21 EPS) YoY; operating loss $2.94M.
- Raised $2.35M from convertible note and registered direct offering in Q2.
- Entered ATM sales agreement for up to $2.5M; raised additional $870K post-quarter.
- Cash $55K at Sept 30, 2023; working capital $100K; clinical trial data for Spryng released.

## SEC filing metadata
- accession: 0001493152-23-040985
- form_type: 8-K
- ticker: PETV
- cik: 0001512922
- company_name: PetVivo Holdings, Inc.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512922/000149315223040985/0001493152-23-040985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512922/000149315223040985/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-040985
- JSON: https://secwatch.observer/filing/0001493152-23-040985.json
- Plain text: https://secwatch.observer/filing/0001493152-23-040985.txt

## Key facts
- Earnings Releases
  PetVivo Holdings, Inc. reported three months ended September 30, 2023 results: revenue $207,366, net income $3,661,153, EPS ($0.28) per share.
  - Period: three months ended September 30, 2023
  - Revenue: $207,366
  - Net income: $3,661,153
  - EPS: ($0.28) per share
  - Result: reported results
  source text: Second Quarter Financial Results For The Three Months Ended September 30, 2023 Compared to The Three Months Ended September 30, 2022 Total Revenues . Revenues were $207,366 and $223,280 for three months ended September 30, 2023 and 2022, respectively. Revenues in the three months ended September 30, 2023 consist of sales of our SpryngTM product to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512922/000149315223040985/0001493152-23-040985-index.htm
- Earnings Releases
  PetVivo Holdings, Inc. reported six months ended September 30, 2023 results: revenue $324,549, net income $6,554,730, EPS ($0.53) per share.
  - Period: six months ended September 30, 2023
  - Revenue: $324,549
  - Net income: $6,554,730
  - EPS: ($0.53) per share
  - Result: reported results
  source text: of shares outstanding was 12,987,641 and 10,053,463 for the three months ended September 30, 2023 and 2022, respectively. Year to Date Financial Results Revenues . Revenues were $324,549 for six the months ended September 30, 2023 compared to revenues of $281,454 in the six months ended September 30, 2022. Revenues in the six months ended September 30, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512922/000149315223040985/0001493152-23-040985-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.